Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration - PubMed (original) (raw)
Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration
V L Smith-Swintosky et al. J Neurochem. 1997 Nov.
Free article
Abstract
Protease-activated receptor-2 (PAR-2) is a seven-transmembrane G protein-coupled receptor that possesses a structure and activation mechanism similar to those of the thrombin receptor. It is activated by low concentrations of trypsin (300 pM) and a synthetic hexapeptide [sequence of serine, leucine, isoleucine, glycine, arginine, leucine (SLIGRL), the rodent PAR-2 "tethered ligand"] representing the first six amino acids following the putative PAR-2 cleavage site. Previous studies have indicated that alpha-thrombin and SFLLRN (synthetic hexapeptide sequence of serine, phenylalanine, leucine, leucine, arginine, asparagine; the human thrombin receptor "tethered ligand") induce neurite retraction and neurotoxicity. Because of the strong similarities between thrombin receptor and PAR-2, we have proposed that PAR-2 may also participate in neurodegeneration. In the present study, we used reverse transcriptase polymerase chain reaction and immunocytochemistry to provide the first evidence that PAR-2 is present in the rat hippocampus. Moreover, we found SLIGRL to be toxic to hippocampal neurons in a concentration-dependent manner (> or = 100 microM). Calcium signaling studies were performed to aid in determining the mechanism by which PAR-2 activation is neurotoxic.
Similar articles
- Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells.
Hwa JJ, Ghibaudi L, Williams P, Chintala M, Zhang R, Chatterjee M, Sybertz E. Hwa JJ, et al. Circ Res. 1996 Apr;78(4):581-8. doi: 10.1161/01.res.78.4.581. Circ Res. 1996. PMID: 8635215 - Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells.
Ubl JJ, Vöhringer C, Reiser G. Ubl JJ, et al. Neuroscience. 1998 Sep;86(2):597-609. doi: 10.1016/s0306-4522(97)00686-6. Neuroscience. 1998. PMID: 9881872 - Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes.
Santulli RJ, Derian CK, Darrow AL, Tomko KA, Eckardt AJ, Seiberg M, Scarborough RM, Andrade-Gordon P. Santulli RJ, et al. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9151-5. doi: 10.1073/pnas.92.20.9151. Proc Natl Acad Sci U S A. 1995. PMID: 7568091 Free PMC article. - Thrombin receptor antagonists; recent advances in PAR-1 antagonist development.
Anderluh M, Dolenc MS. Anderluh M, et al. Curr Med Chem. 2002 Jul;9(13):1229-50. doi: 10.2174/0929867023369934. Curr Med Chem. 2002. PMID: 12052165 Review. - Thrombin receptor antagonists: a work in progress.
Brass LF. Brass LF. Coron Artery Dis. 1997 Jan;8(1):49-58. doi: 10.1097/00019501-199701000-00008. Coron Artery Dis. 1997. PMID: 9101123 Review.
Cited by
- Protease-Activated Receptors (PARs): Biology and Therapeutic Potential in Perioperative Stroke.
Mavridis T, Choratta T, Papadopoulou A, Sawafta A, Archontakis-Barakakis P, Laou E, Sakellakis M, Chalkias A. Mavridis T, et al. Transl Stroke Res. 2024 Feb 7. doi: 10.1007/s12975-024-01233-0. Online ahead of print. Transl Stroke Res. 2024. PMID: 38326662 Review. - Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism.
de Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, Ossovskaya VS, D'Andrea MR, Mayer EA, Wallace JL, Hollenberg MD, Andrade-Gordon P, Bunnett NW. de Garavilla L, et al. Br J Pharmacol. 2001 Aug;133(7):975-87. doi: 10.1038/sj.bjp.0704152. Br J Pharmacol. 2001. PMID: 11487506 Free PMC article. - Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.
Kempuraj D, Selvakumar GP, Thangavel R, Ahmed ME, Zaheer S, Kumar KK, Yelam A, Kaur H, Dubova I, Raikwar SP, Iyer SS, Zaheer A. Kempuraj D, et al. J Alzheimers Dis. 2018;66(3):1117-1129. doi: 10.3233/JAD-180786. J Alzheimers Dis. 2018. PMID: 30372685 Free PMC article. - Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C. Noorbakhsh F, et al. J Exp Med. 2006 Feb 20;203(2):425-35. doi: 10.1084/jem.20052148. Epub 2006 Feb 13. J Exp Med. 2006. PMID: 16476770 Free PMC article. - Electroacupuncture intervention of visceral hypersensitivity is involved in PAR-2-activation and CGRP-release in the spinal cord.
Shah MK, Ding Y, Wan J, Janyaro H, Tahir AH, Vodyanoy V, Ding MX. Shah MK, et al. Sci Rep. 2020 Jul 7;10(1):11188. doi: 10.1038/s41598-020-67702-2. Sci Rep. 2020. PMID: 32636402 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources